MPN Hope: How Besremi and Clinical Trial is Managing my PV

Francesc, from Spain, shares his incredible journey of managing Polycythemia Vera (PV) with the help of Besremi and a clinical trial. As a patient with a JAK2 mutation, Francesc’s allele burden initially sat at 97%, but after starting the treatment, it has drastically dropped to nearly nonexistent.

This remarkable shift in his JAK2 allele burden has not only stabilized his condition but has also had a profound impact on his overall quality of life. Francesc’s story highlights the potential of Besremi and clinical trials to make a real difference in managing PV symptoms and improving daily life.

In his exclusive testimony, Francesc explains how Besremi helped reduce his symptoms, control his blood counts, and bring a renewed sense of hope. His experience is a shining example of how the right treatment can lead to extraordinary results.

Want to see how Besremi and clinical trials are offering new hope for PV patients? Without the clinical trial he would not have this positive result. Watch the Part 1:

🔗 Watch the full video on MPN World

If you're living with Polycythemia Vera or any other MPN, remember, there’s hope. The right treatment can bring transformative changes, and we’re here to support you every step of the way.

If you're not a patient and want to see the full video, please contact us at info@gmpnsf.org.